The effect of omega-3 in the prevention of cardiac complications after PCI

The effect of Omega-3 polyunsaturated fatty acids (PUFAs) in serum CK-MB and Troponin I as markers of myocardial injury after PCI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016072329035N1

Enrollment

100

Registered

2016-09-08

Start date

2016-09-07

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic ischaemic heart disease. Atherosclerotic heart disease

Interventions

Intervention 1: placebo/ 12 hours before PCI/stat. Intervention 2: omega-3/ 3gr/ 12hours before PCI/ stat.

Placebo

Treatment - Drugs

placebo/ 12 hours before PCI/stat

omega-3/ 3gr/ 12hours before PCI/ stat

Eligibility

Sex/Gender

All

Age

36 Years to 68 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients who require elective PCI; patients with angiographic indications for PCI; patients with personal satisfaction conscious to taking part in the study . Exclusion criteria: patients who require emergency PCI; renal insufficiency; treatment with anticoagulant drugs; myocarditis or myopericarditis; myopathies; infection and chemotherapy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Troponin I. Timepoint: Before PCI and 24 hours after PCI. Method of measurement: Blood test.;CK-MB. Timepoint: Before PCI and 24 hours after PCI. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Leili Avesta

Ardabil University of Medical Sciences

h.alinia@arums.ac.ir+98 45 3351 2006

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026